Dakwar, Elias

A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial

Dakwar, E., Nunes, E. V., Hart, C. L., Foltin, R. W., Mathew, S. J., Carpenter, K. M., Choi, C. J. “., Basaraba, C. N., Pavlicova, M., & Levin, F. R. (2019) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesOpioid Use Disorder Treatment

Cited by 186

A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial

Dakwar, E., Levin, F., Hart, C. L., Basaraba, C., Choi, J., Pavlicova, M., & Nunes, E. V. (2020) · American Journal of Psychiatry

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 183

The Effects of Subanesthetic Ketamine Infusions on Motivation to Quit and Cue-Induced Craving in Cocaine-Dependent Research Volunteers

Dakwar, E., Levin, F., Foltin, R. W., Nunes, E. V., & Hart, C. L. (2014) · Biological Psychiatry

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 143

Therapeutic infusions of ketamine: do the psychoactive effects matter?

Dakwar, E., Anerella, C., Hart, C. L., Levin, F. R., Mathew, S. J., & Nunes, E. V. (2014) · Drug and Alcohol Dependence

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 123

Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial.

Levin, F. R., Mariani, J. J., Pavlicova, M., Brooks, D., Glass, A., Mahony, A., Nunes, E. V., Bisaga, A., Dakwar, E., Carpenter, K. M., et al. (2016) · Drug and Alcohol Dependence

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 109

Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, crossover trial

Dakwar, E., Hart, C. L., Levin, F. R., Nunes, E. V., & Foltin, R. W. (2017) · Molecular Psychiatry

Neurotransmitter Receptor Influence on BehaviorSubstance Abuse Treatment and Outcomes

Cited by 105

Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial

Rothberg, R. L., Azhari, N., Haug, N. A., & Dakwar, E. (2021) · Journal of Psychopharmacology

Psychedelics and Drug StudiesSubstance Abuse Treatment and Outcomes

Cited by 97

A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine on cocaine use disorder: Results from a randomized, controlled laboratory study

Dakwar, E., Nunes, E. V., Hart, C. L., Hu, M. C., Foltin, R. W., & Levin, F. R. (2018) · Neuropharmacology

Psychedelics and Drug StudiesTreatment of Major Depression

Cited by 85

Mindfulness impairments in individuals seeking treatment for substance use disorders

Dakwar, E., Mariani, J. P., & Levin, F. R. (2011) · The American Journal of Drug and Alcohol Abuse

Mindfulness and Compassion InterventionsSubstance Abuse Treatment and Outcomes

Cited by 55

Extended release mixed amphetamine salts and topiramate for cocaine dependence: A randomized clinical replication trial with frequent users

Levin, F. R., Mariani, J. J., Pavlicova, M., Choi, C. J., Mahony, A. L., Brooks, D. J., Bisaga, A., Dakwar, E., Carpenter, K. M., Naqvi, N., et al. (2020) · Drug and Alcohol Dependence

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on Behavior

Cited by 54

Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study

Azhari, N., Hu, H., O’Malley, K. Y., Blocker, M. E., Levin, F. R., & Dakwar, E. (2021) · The American Journal of Drug and Alcohol Abuse

Substance Abuse Treatment and OutcomesTreatment of Major Depression

Cited by 48

Guanfacine extended-release for cannabis use disorder: A pilot feasibility trial

Dakwar, E., Mahony, A., Choi, C. J., Pavlicova, M., Brooks, D., Mariani, J. J., & Levin, F. R. (2020) · The American Journal of Drug and Alcohol Abuse

Cannabis and Cannabinoid ResearchSubstance Abuse Treatment and Outcomes

Cited by 5